Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simrat Randhawa Insider Profile
4 Followers
Simrat Randhawa, CMO at Dianthus Therapeutics, holds 4.00K shares in Dianthus Therapeutics (Ticker: DNTH). Most recently, Simrat Randhawa Bought $4,000 shares of Dianthus Therapeutics on Sep 25, 2023 for an estimated value of 52.80K.
Simrat Randhawa has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Simrat Randhawa's holdings
Insider Roles
CMO
Roles that Simrat Randhawa holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Simrat Randhawa
Simrat Randhawa's Trading History
List of latest transactions for each holding click on a transaction to see Simrat Randhawa's performance on stock
You May Also Like
Simrat Randhawa insider profile FAQ
What is the percentage of profitable transactions made by Simrat Randhawa?
The percentage of profitable transactions made by Simrat Randhawa is ―.
What is the average return per transaction made by Simrat Randhawa?
The average return per transaction made by Simrat Randhawa is ―.
What stocks does Simrat Randhawa hold?
Simrat Randhawa holds: DNTH stocks.
What was Simrat Randhawa’s latest transaction?
Simrat Randhawa latest transaction was an Informative Buy of $52.80K.
What was Simrat Randhawa's most profitable transaction?
Simrat Randhawa’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Simrat Randhawa's role in Dianthus Therapeutics?
Simrat Randhawa's role in Dianthus Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.